←Back to Expert Scholars
Translational Medicine / 转化医学NSCLC, Targeted Therapy
Karen Reckamp
MD, MS
🏢Cedars-Sinai Medical Center🌐USA
Director, Division of Medical Oncology
65
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Karen Reckamp is a thoracic oncologist leading trials in oncogene driven NSCLC including EGFR and MET altered disease. She focuses on young and never smoker patients and integrates liquid biopsy for treatment selection. Her work has shaped standard of care for targeted therapy in NSCLC.
Share:
🧪Research Fields 研究领域
NSCLC
targeted therapy
young lung cancer
liquid biopsy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Karen Reckamp 的研究动态
Follow Karen Reckamp's research updates
留下邮箱,当我们发布与 Karen Reckamp(Cedars-Sinai Medical Center)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment